For the purposes of the Committee, when focusing on research to evaluate environmental and genomic factors that may be related to the etiology of breast cancer, nothing in this section shall be construed to restrict the Secretary from including other forms of cancer, as appropriate, when doing so may advance research in breast cancer or advance research in other forms of cancer.
42 U.S. Code § 285a–12. Interagency Breast Cancer and Environmental Research Coordinating Committee
(a) Interagency Breast Cancer and Environmental Research Coordinating Committee
(2) DutiesThe Committee shall—
(B) develop a comprehensive strategy and advise the National Institutes of Health and other Federal agencies in the solicitation of proposals for collaborative, multidisciplinary research, including proposals to evaluate environmental and genomic factors that may be related to the etiology of breast cancer that would—
result in innovative approaches to study emerging scientific opportunities or eliminate knowledge gaps in research to improve the research portfolio;
expand the number of collaborative, multidisciplinary, and multi-institutional research grants;
(D) not later than 2 years after the date of the establishment of the Committee, make recommendations to the Secretary—
regarding any appropriate changes to research activities, including recommendations to improve the research portfolio of the National Institutes of Health to ensure that scientifically-based strategic planning is implemented in support of research priorities that impact breast cancer research activities;
to ensure that the activities of the National Institutes of Health and other Federal agencies, including the Department of Defense, are free of unnecessary duplication of effort;
(3) Rule of construction
(A) In generalThe Committee shall be composed of the following voting members:
(i) Not more than 7 voting Federal representatives as follows:
The Director of the Centers for Disease Control and Prevention.
Representatives of other Federal agencies that conduct or support cancer research, including the Department of Defense.
(B) Additional membersThe Committee shall include additional voting members appointed by the Secretary as follows:
(i) 6 members shall be appointed from among scientists, physicians, and other health professionals, who—
6 members shall be appointed from members of the general public, who represent individuals with breast cancer.